Siemens Healthineers AG Stock Deutsche Boerse AG

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate 14:04:52 2024-06-10 EDT 5-day change 1st Jan Change
54.75 EUR -0.05% Intraday chart for Siemens Healthineers AG +2.62% +3.16%

Financials

Sales 2024 * 22.68B 24.4B 33.56B Sales 2025 * 24.25B 26.09B 35.89B Capitalization 61.48B 66.15B 90.98B
Net income 2024 * 2.02B 2.17B 2.99B Net income 2025 * 2.56B 2.75B 3.78B EV / Sales 2024 * 3.23 x
Net Debt 2024 * 11.87B 12.77B 17.57B Net Debt 2025 * 10.52B 11.32B 15.57B EV / Sales 2025 * 2.97 x
P/E ratio 2024 *
30.6 x
P/E ratio 2025 *
24.2 x
Employees 71,000
Yield 2024 *
1.86%
Yield 2025 *
2.25%
Free-Float 23.56%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.05%
1 week+2.62%
Current month+2.28%
1 month+4.10%
3 months-3.89%
6 months+5.35%
Current year+3.16%
More quotes
1 week
52.64
Extreme 52.64
55.34
1 month
52.62
Extreme 52.62
55.34
Current year
49.85
Extreme 49.85
58.16
1 year
44.46
Extreme 44.46
58.16
3 years
40.53
Extreme 40.53
67.88
5 years
28.51
Extreme 28.505
67.88
10 years
28.51
Extreme 28.505
67.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 17-12-31
Director of Finance/CFO 57 17-12-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 64 22-10-31
Director/Board Member 57 21-03-22
Director/Board Member 72 18-02-28
More insiders
Date Price Change Volume
24-06-10 54.78 0.00% 12
24-06-07 54.78 -0.18% 489
24-06-06 54.88 +0.88% 501
24-06-05 54.4 +2.84% 1,389
24-06-04 52.9 -0.90% 20

Delayed Quote Deutsche Boerse AG, June 10, 2024 at 05:28 am

More quotes
Siemens Healthineers AG is one of the world's No.1 manufacturers of equipment for medical imaging, laboratory diagnostics and hospital information systems. In addition, the group is developing digital health services and services dedicated to health establishments. Net sales break down by activity as follows: - sale of imaging equipment and solutions (53%); - sale of diagnostic equipment (21%); - sale of solutions and services for cancer care (16.6%); - sale of advanced therapeutic solutions (9.4%): for image-guided minimally invasive treatments in the areas of cardiology, interventional radiology and surgery. Net sales are distributed geographically as follows: Germany (4.9%), Europe/CIS/Africa/Middle East (27.3%), the United States (34.6%), America (6.3%), China (13%) and Asia/Pacific and Japan (13.9%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
55.1 EUR
Average target price
60.47 EUR
Spread / Average Target
+9.74%
Consensus